JAT vs BUBS why the huge price differences??
I would appreciate some objective views on why the share price at Friday close for JAT = $0.06 vs BUBS = $1.17 ???
It would seem based on what I can see below is that JAT is massively undervalued given its revenue generation capacity is already greater than BUBS and with the addition of the new manufacturing facility it will likely leap even further ahead. It has also signed significant Joint-venture contracts with Chinese companies outlets.....
What am I missing here?? Is it timing thing and/or marketing edge that BUBS has over JAT or what??
When I did the comparisons using the Appendix 4C for both companies these are what I found.
1) Revenue from Sales Year-to-date (12MONTHS)
JAT = $67,212,000
BUBS = $40,030,000
2) Revenue from Sales Current quarter
JAT = $17,895,000
BUBS = $14,737,000
3) Cash at end of Current quarter
JAT = $7, 830,000
BUBS = $23,291,000 (This largely from share sale $32,738,000)
4) Major Capital Investment in Product manufacturing
JAT = $21,000,000 (ANMA Production Plant + other costs)
BUBS = $0
5) Total Shares
JAT = 798m
BUBS = 596m
6) Market Cap
JAT = $47.90M
BUBS = $596.2M
- Forums
- ASX - By Stock
- JAT
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-808
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.0¢ |
Change
-0.025(4.85%) |
Mkt cap ! $40.80M |
Open | High | Low | Value | Volume |
51.0¢ | 51.0¢ | 49.0¢ | $10.15K | 20.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 10855 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.480 |
1 | 2150 | 0.460 |
2 | 26000 | 0.455 |
3 | 31132 | 0.450 |
2 | 52000 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 10855 | 4 |
0.550 | 39565 | 1 |
0.560 | 12073 | 3 |
0.590 | 20000 | 1 |
0.600 | 103269 | 1 |
Last trade - 11.49am 08/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online